ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma

Author:

Sheybani Natasha D.,Breza Victoria R.,Paul Soumen,McCauley Katelyenn S.,Berr Stuart S.,Miller G. Wilson,Neumann Kiel D.,Price Richard J.

Funder

National Institute of Neurological Disorders and Stroke

National Cancer Institute

NIH Office of the Director

National Institute of Biomedical Imaging and Bioengineering

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference61 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

2. Immune evasion strategies of glioblastoma;Razavi;Front. Surg.,2016

3. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors;Gholamin;Sci. Transl. Med.,2017

4. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma;Hutter;Proc. Natl. Acad. Sci.,2019

5. Anti-CD47 treatment stimulates phagocytosis of glioblastoma by M1 and M2 polarized macrophages and promotes M1 polarized macrophages in vivo;Zhang;PLoS One,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3